Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

他のバージョン（2件）を表示する

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries, with an increasing prevalence due to an aging population. The pathology underpinning CVD is atherosclerosis, a chronic inflammatory state involving the arterial wall. Accumulation of low density lipo...

書誌詳細
主要な著者:	Psarros, C, Lee, R, Margaritis, M, Antoniades, C
フォーマット:	Journal article
言語:	English
出版事項:	2012

類似資料

Nanomedicine for the prevention, treatment and imaging of atherosclerosis
著者:: Psarros, C, 等
出版事項: (2012)

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
著者:: Psarros, C, 等
出版事項: (2012)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
著者:: Jingyun Cheng, 等
出版事項: (2023-12-01)

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
著者:: Shuihua Zhang, 等
出版事項: (2020-01-01)

The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
著者:: Antonopoulos, A, 等
出版事項: (2010)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
著者:: Yongfang Lin, 等
出版事項: (2024-06-01)

Nanoparticles: a promising therapeutic approach in atherosclerosis.
著者:: Antoniades, C, 等
出版事項: (2010)

Biomimetic nanomedicines for precise atherosclerosis theranostics
著者:: Ying Tao, 等
出版事項: (2023-11-01)

Editorial: Advances on targeted nanomedicines for atherosclerosis
著者:: Qinggong Han, 等
出版事項: (2022-10-01)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
著者:: Antonopoulos, A, 等
出版事項: (2009)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
著者:: Ping Ping Hu, 等
出版事項: (2022-09-01)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
著者:: Xue Li, 等
出版事項: (2022-10-01)

Statin treatment improves vascular redox state through a tetrahydrobiopterin-mediated re-coupling of endothelial nitric oxide synthase, in human atherosclerosis
著者:: Antoniades, C, 等
出版事項: (2011)

Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
著者:: D. Gao, 等
出版事項: (2020-01-01)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
著者:: Yee Shan Wong, 等
出版事項: (2019-01-01)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
著者:: Yee Shan Wong, 等

Interrelationships between vascular superoxide and adiponectin biosynthesis in perivascular adipose tissue in human atherosclerosis
著者:: Bakogiannis, C, 等
出版事項: (2010)

Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
著者:: Zhiyue Wang, 等
出版事項: (2024-12-01)

Nanomedicine for renal cell carcinoma: imaging, treatment and beyond
著者:: Ruolin Wu, 等
出版事項: (2023-01-01)

Adiponectin as a regulator of vascular redox state in human atherosclerosis
著者:: Margaritis, M
出版事項: (2016)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
著者:: Siasos, G, 等
出版事項: (2007)

A NOVEL CROSS-TALK BETWEEN PERIVASCULAR ADIPOSE TISSUE AND THE ARTERIAL WALL CONTROLS REDOX STATE IN HUMAN ATHEROSCLEROSIS
著者:: Margaritis, M, 等
出版事項: (2013)

A novel cross-talk between perivascular adipose tissue and the arterial wall controls redox state in human atherosclerosis
著者:: Margaritis, M, 等
出版事項: (2013)

Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition
著者:: Akoumianakis, I, 等
出版事項: (2020)

Macrophage-targeting Antisenescence nanomedicine enables in-Situ NO induction for Gaseous and antioxidative atherosclerosis intervention
著者:: Yuanyuan Peng, 等
出版事項: (2025-06-01)

Insulin Treatment Induces Oxidative Stress in the Vascular Wall of Patients With Atherosclerosis Independently of Diabetes or Systemic Insulin Resistance: The Protective Role of DPP-IV Inhibition
著者:: Akoumianakis, I, 等
出版事項: (2018)

Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
著者:: Margaritis, M, 等
出版事項: (2012)

Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux
著者:: Sijin Chen, 等
出版事項: (2024-10-01)

Biomarkers of premature atherosclerosis.
著者:: Kampoli, A, 等
出版事項: (2009)

An immunoregulator nanomedicine approach for the treatment of tuberculosis
著者:: Luona Yang, 等
出版事項: (2023-05-01)

Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
著者:: Antoniades, C, 等
出版事項: (2011)

Challenges to Safe Nanomedicine Treatment
著者:: Chunhua Yang, 等
出版事項: (2023-03-01)

Nanomedicine: Engineering of a tri-imageable nanoparticle for diagnostics
著者:: Bumb, A, 等
出版事項: (2009)

The role of perivascular fat in the diagnosis and prognosis of atherosclerosis
著者:: Polkinghorne, M, 等
出版事項: (2022)

Homocysteine lowering: any use in atherosclerosis?
著者:: Antoniades, C, 等
出版事項: (2007)

Perivascular adipose tissue and coronary atherosclerosis
著者:: Mancio, J, 等
出版事項: (2018)

State-of-the-art review article. Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue?
著者:: Antoniades, C, 等
出版事項: (2019)

Nanomedicine Explored at Molecular Imaging Summit
著者:: Julie L. Sutcliffe PhD
出版事項: (2011-01-01)

The Role of Optical Imaging in Translational Nanomedicine
著者:: Evelien Hesemans, 等
出版事項: (2022-08-01)

Advances in nanomedicines for lymphatic imaging and therapy
著者:: Pan He, 等
出版事項: (2023-08-01)